SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NORTH AMERICAN VACCINE (NVX)
NVX 1.510-3.8%Oct 31 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom Stone who wrote (6)2/23/1997 12:33:00 PM
From: andy harrison   of 21
 
Short interest in NVX is up to 3,773,856 (ending 2/14/97) which
is an 8% increase over last month. Most likely due to the
article (or anticipation of) in Individual Investor magazine.
I guess we own them a show of appreciation for piling more shorts
into the stock. The professional investors I dont feel sorry
for but rather the indiviual investors who will (hopefully)
lose a great deal of money shorting NVX.

NVX only traded 1,471,492 shares from 1/15/97-2/14/97 based
on Barrons listing of average daily volume of 66,886.
That means that almost 20% of the shares traded in NVX for that
time period were shorted. I would say that the stock has again
shown considerable strength.

Once again I suggest that either March or June options be purchased
and the better strategy is to ask for execution of the options
which will force people to have to go into the market and buy
stock, which in turn will drive the stock price up.
I am holding March 22 1/2's which I plan on converting to stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext